IL6 and oral cavity squamous cell carcinoma: Earlier studies have indicated that IL-6 is strongly associated with the development of oral cancer and there are experimental indications that anti-IL-6 receptor antibody reduces angiogenesis and tumor growth in squamous cell oral carcinoma (23, 24).